1. Home
  2. PROK vs TDUP Comparison

PROK vs TDUP Comparison

Compare PROK & TDUP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PROK
  • TDUP
  • Stock Information
  • Founded
  • PROK 2015
  • TDUP 2009
  • Country
  • PROK United States
  • TDUP United States
  • Employees
  • PROK 163
  • TDUP N/A
  • Industry
  • PROK Biotechnology: Biological Products (No Diagnostic Substances)
  • TDUP Catalog/Specialty Distribution
  • Sector
  • PROK Health Care
  • TDUP Consumer Discretionary
  • Exchange
  • PROK Nasdaq
  • TDUP Nasdaq
  • Market Cap
  • PROK 212.4M
  • TDUP 172.9M
  • IPO Year
  • PROK N/A
  • TDUP 2021
  • Fundamental
  • Price
  • PROK $1.66
  • TDUP $2.26
  • Analyst Decision
  • PROK Buy
  • TDUP Buy
  • Analyst Count
  • PROK 5
  • TDUP 5
  • Target Price
  • PROK $4.50
  • TDUP $3.50
  • AVG Volume (30 Days)
  • PROK 566.3K
  • TDUP 1.3M
  • Earning Date
  • PROK 11-12-2024
  • TDUP 03-03-2025
  • Dividend Yield
  • PROK N/A
  • TDUP N/A
  • EPS Growth
  • PROK N/A
  • TDUP N/A
  • EPS
  • PROK N/A
  • TDUP N/A
  • Revenue
  • PROK N/A
  • TDUP $313,757,000.00
  • Revenue This Year
  • PROK N/A
  • TDUP N/A
  • Revenue Next Year
  • PROK N/A
  • TDUP N/A
  • P/E Ratio
  • PROK N/A
  • TDUP N/A
  • Revenue Growth
  • PROK N/A
  • TDUP 0.58
  • 52 Week Low
  • PROK $1.18
  • TDUP $0.50
  • 52 Week High
  • PROK $4.44
  • TDUP $2.45
  • Technical
  • Relative Strength Index (RSI)
  • PROK 46.29
  • TDUP 71.74
  • Support Level
  • PROK $1.50
  • TDUP $1.21
  • Resistance Level
  • PROK $1.90
  • TDUP $1.59
  • Average True Range (ATR)
  • PROK 0.15
  • TDUP 0.19
  • MACD
  • PROK -0.01
  • TDUP 0.09
  • Stochastic Oscillator
  • PROK 45.45
  • TDUP 84.68

About PROK ProKidney Corp.

ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's own cells isolated from the patient intended for treatment. Its lead product candidate, REACT (Renal Autologous Cell Therapy) is a disease-modifying cell therapy made from a patient's own renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. The company's pipeline consists of development program for severe diabetic kidney disease.

About TDUP ThredUp Inc.

ThredUp Inc is an online resale platform for women and kids apparel, shoes, and accessories. It generates revenue from items that are sold to buyers through the website, mobile app, and RaaS partners. Geographically, the majority of the company's revenue is generated from United States.

Share on Social Networks: